Expertise in
10
conditions

Dr. Robert L. Debernardo

Surgical Oncology
9500 Euclid Avenue, 
Cleveland, OH 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
10
conditions
9500 Euclid Avenue, 
Cleveland, OH 

Overview

Robert Debernardo is a Surgical Oncologist practicing medicine in Cleveland, Ohio.

Dr. Debernardo is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Melanoma, Familial Colorectal Cancer, Gastrostomy, and Hernia Surgery.

Dr. Debernardo is board certified in American Board Of Obstetrics And Gynecology, 2007. He is actively involved in clinical research, co-authoring 67 peer reviewed articles and participating in 2 clinical trials. Dr. Debernardo is currently accepting new patients.

Specialties

Surgical Oncology

Licenses

Obstetrics & Gynecology in OH

Board Certifications

American Board Of Obstetrics And Gynecology, 2007

Fellowships

Massachusetts General Hospital

Hospital Affiliations

Akron General Medical Center
Cleveland Clinic
Hillcrest Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 24 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
9500 Euclid Avenue, Cleveland, OH 44195
Other Locations
Hillcrest Hospital
6780 Mayfield Road, Mayfield Hts, OH 44124
Cleveland Clinic Main Campus
10201 Carnegie Avenue, Cleveland, OH 44106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I Proof-of-Concept Study of Artesunate Ointment for the Treatment of Patients With High-Grade Vulvar Intraepithelial Neoplasia (HSIL VIN 2/3)
A Phase I Proof-of-Concept Study of Artesunate Ointment for the Treatment of Patients With High-Grade Vulvar Intraepithelial Neoplasia (HSIL VIN 2/3)
Enrollment Status: Completed
Publish Date: December 04, 2024
Intervention Type: Drug
Study Phase: Phase 1
Optimization of Parameters for Ureterolysis During Minimally Invasive Hysterectomy; Determining Variation in Ureter Position and Degree of Thermal Spread
Optimization of Parameters for Ureterolysis During Minimally Invasive Hysterectomy; Determining Variation in Ureter Position and Degree of Thermal Spread
Enrollment Status: Withdrawn
Publish Date: February 27, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

67 Total Publications

Correction: CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.
Correction: CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.
Journal: The Journal of experimental medicine
Published: July 30, 2026
Similar Doctors
Expertise in
16
conditions
Dr. Jordan M. Winter
Surgical Oncology | General Surgery
Expertise in
16
conditions
Dr. Jordan M. Winter
Surgical Oncology | General Surgery
Referral may be required

University Hospitals

11100 Euclid Ave, 
Cleveland, OH 
 (0.9 miles away)
216-844-5777
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jordan Winter is a Surgical Oncologist and a General Surgeon practicing medicine in Cleveland, Ohio. Dr. Winter is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Winter is currently accepting new patients.

Expertise in
10
conditions
Dr. Julie E. Lang
Surgical Oncology
Expertise in
10
conditions
Dr. Julie E. Lang
Surgical Oncology
Referral may be required
Before you request

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.1 miles away)
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

Julie Lang is a Surgical Oncologist practicing medicine in Cleveland, Ohio. Dr. Lang is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Lymphadenectomy. Dr. Lang is board certified in American Board Of Surgery, 2006. Dr. Lang is currently accepting new patients.

Expertise in
10
conditions
Dr. Chad M. Michener
Surgical Oncology
Expertise in
10
conditions
Dr. Chad M. Michener
Surgical Oncology
Referral may be required
Before you request

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (0.3 miles away)
866-223-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chad Michener is a Surgical Oncologist practicing medicine in Cleveland, Ohio. Dr. Michener is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Eccrine Porocarcinoma, Melanoma, Desmoplastic Small Round Cell Tumor, Endoscopy, and Hernia Surgery. Dr. Michener is board certified in American Board Of Obstetrics And Gynecology, 2008. Dr. Michener is currently accepting new patients.

Frequently Asked Questions about Dr. Robert L. Debernardo

How do I make an appointment with Dr. Robert L. Debernardo?

You can book an appointment with Dr. Robert L. Debernardo by calling their office at 440-312-4500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert L. Debernardo a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert L. Debernardo is classified as an Advanced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert L. Debernardo specialize in?

While Dr. Robert L. Debernardo is a Surgical Oncology, they have specific expertise in Adult Soft Tissue Sarcoma, Melanoma, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.

Does Dr. Robert L. Debernardo participate in research or clinical trials?

Yes. Dr. Robert L. Debernardo has published 67 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Dr. Robert L. Debernardo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robert L. Debernardo accept my insurance?

Dr. Robert L. Debernardo accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 440-312-4500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Debernardo's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 42 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile